AMY MALONE: Open Payments
NPI 1063412468 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,364 in 97 payments from 26 companies in 2025. Trend: 2023 $1,890 · 2024 $2,205 · 2025 $2,364
Food & beverage: $2,185Education: $179
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $266 |
| AstraZeneca Pharmaceuticals LP | 14 | $255 |
| ABBVIE INC. | 7 | $231 |
| Regeneron Healthcare Solutions, Inc. | 5 | $199 |
| GlaxoSmithKline, LLC. | 5 | $181 |
| E.R. Squibb & Sons, L.L.C. | 13 | $172 |
| Tempus AI, Inc | 5 | $142 |
| Incyte Corporation | 5 | $125 |
| Merck Sharp & Dohme LLC | 5 | $99 |
| PFIZER INC. | 4 | $94 |
Products named: DARZALEX, LIBTAYO, XT CDX, JEMPERLI, VENCLEXTA, OPDIVO, IMJUDO, IMFINZI.
Industry payments across TX — which companies pay providers there.
